The global Parkinson’s disease treatment market is expected to grow at a CAGR of over 6% during the forecast period. The factors that drive the growth of the market include the increased prevalence of Parkinson’s disease across the globe. As per the Institute for Health Metrics and Evaluation in 2019, around 10 million people suffered from Parkinson’s disease globally. Every year more than a million incidences of Parkinson’s disease are registered globally, which is expected to drive the global Parkinson’s disease treatment market in the near future.
(Get 15% Discount on Buying this Report)
Get Report Sample Copy @
https://www.omrglobal.com/request-sample/parkinsons-disease-treatment-market
Rising geriatric population is one of the major factors that is expected to surge the market growth during the forecast period. The elderly population is at increased risk of developing Parkinson's disease, which in turn creates scope for the growth of the Parkinson’s disease treatment market during the forecast period. However, lack of awareness and poor reimbursement policies in several developing economies is anticipated to hinder the growth of the market during the forecast period.Besides, several R&D activities concerning the development of the novel drugs will create ample opportunities for market growth in the near future.
A Full Report is Available at:
https://www.omrglobal.com/industry-reports/parkinsons-disease-treatment-market
Segmental Outlook
The global Parkinson’s disease treatment market is segmented on the basis of type into drug and surgical procedures. Based on the drug class, the market is segmented into dopamine receptor agonists, MAO-inhibitors, carbidopa-levodopa, catechol o-methyltransferase (COMT) inhibitors, anticholinergics, and others. The other segment further includes amantadine and selegiline. Based on the surgical procedures, the market is segmented into deep brain stimulation, vagus nerve stimulation, and others that include pallidotomy and thalamotomy.

Deep Brain Stimulators Segment to Hold a Significant Share
Amongst the surgical procedures segment of the market, deep brain stimulators segment is estimated to hold the most significant share in the market. Patients with moderate disabilities from Parkinson’s disease can opt for surgical procedures. Deep brain stimulators are used for controlling and lessening the symptoms of Parkinson's disease. The segmental growth is accredited to the rising incidence of Parkinson’s disease. Several novel product launches have been observed significantly in the market, for instance, in January 2019, Boston Scientific Corp. launched two deep brain stimulation systems including Vercise Gevia and non-rechargeable Vercise Primary Cell systems. Thus, this is expected to drive the segmental market growth.

Regional Outlook
The global Parkinson’s disease treatment market is geographically segmented as North America, Europe, Asia-Pacific and Rest of the World. The North American region is estimated to hold a prominent share in the global market. The regional growth is attributed to the increasing incidences of Parkinson’s diseases in the region. According to the report of Parkinson’s Canada, Parkinson’s disease affects 1 in every 500 people in Canada. In 2018, over 100,000 Canadians were living with Parkinson’s and around 6,600 new cases of Parkinson’s disease are estimated to be diagnosed each year in Canada (based on the annual incidence of 20 new cases per 100,000 people). Therefore, the utility of DBS for the treatment of Parkinson’s disease coupled with a large customer base in Canada is projected to drive the growth of the market in Canada. Further, the US contributes significantly to the market due to huge expenditure on healthcare by the government and the adoption of innovative technologies in the healthcare domain.

Market Players Outlook
Some of the prominent players operating in the global Parkinson’s diseases treatment market include Medtronic Plc, AbbVie Inc., Boehringer Ingelheim GmbH, GlaxoSmithKline Plc, Boston Scientific Corp., Cipla Inc., Mylan NV, Novartis International AG, Eli Lilly& Co., Pfizer Inc., and Teva Pharmaceutical Industries Ltd.among others. These manufacturers are adopting various strategies such as new product launches and approvals, merger and acquisition, partnerships and collaborations, and many others to thrive in a competitive environment.

For instance, since May 2018, after the preclinical studies by Eli Lilly, it declared that enhancing dopamine receptor D1 aids in improving cognitive function.Eli Lilly is engaged in the development of LY3154207. The novel drug is an orally administered enhancer of dopamine receptor D1, which is a sort of dopamine receptor involved in cognition for the treatment of Parkinson’s disease. In addition, in October 2019, the US FDA approved a novel drug Nourianz (istradefylline) for Parkinson’s “Off” time manufactured by Kyowa KirinInc.

The Report Covers
Market value data analysis of 2018 and forecast to 2025.
Annualized market revenues ($ million) for each market segment.
Country-wise analysis of major geographical regions.
Key companies operating in the global Parkinson’s disease treatment market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
Analysis of market-entry and market expansion strategies.
Competitive strategies by identifying ‘who-stands-where’ in the market.
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @
https://www.omrglobal.com/industry-reports/parkinsons-disease-treatment-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected]
Contact no: +91 780-304-0404